Soleno Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Soleno Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Soleno Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Soleno Therapeutics Inc. is SLNO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Soleno Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade Soleno Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Soleno Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Soleno Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Soleno Therapeutics Inc..